Concepedia

Melynda Watkins

MW

5

Publications

88

Citations

5

H-Index

2016

Active since

Affiliations

Clinton Health Access Initiative(Current)

International AIDS Society

Scynexis (United States)

United States Department of State

World Health Organization

Melynda Watkins is an author at Clinton Health Access Initiative specializing in drug discovery, hiv, and drug development.

Top concepts

Publications per year

2016–2023

5

Publications

5

Shortening the decade‐long gap between adult and paediatric drug formulations: a new framework based on the HIV experience in low‐ and middle‐income countries

Martina Penazzato, Linda Lewis, Melynda Watkins et al. · Journal of the International AIDS Society · 2018 · 22 citations · Full text

Catalysing the development and introduction of paediatric drug formulations for children living with HIV: a new global collaborative framework for action

Martina Penazzato, Melynda Watkins, Sébastien Morin et al. · The Lancet HIV · 2018 · 22 citations

, , +8

Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate

Melynda Watkins, Steve Wring, Ryan Randolph et al. · Journal of Pharmaceutical Sciences · 2016 · 21 citations · Full text

Securing accelerated access to long‐acting injectable cabotegravir for HIV prevention in low‐ and middle‐income countries

Sarah Yardly Jenkins, Danielle Resar, Zachary Panos et al. · Journal of the International AIDS Society · 2023 · 12 citations · Full text

Simulating Intestinal Transporter and Enzyme Activity in a Physiologically Based Pharmacokinetic Model for Tenofovir Disoproxil Fumarate

Darren Moss, Paul L. Domanico, Melynda Watkins et al. · Antimicrobial Agents and Chemotherapy · 2017 · 11 citations · Full text

Rows per page

1–5 of 5